Moreover, specific class–event associations were highlighted by Johnson who showed that encephalitis and myasthenia gravis were mainly related to treatments with anti-PD-1/PD-L1 agents, while GBS and meningitis were mainly related to anti-CTLA-4 combination therapies. This evidence concerns the gene CTLA4 and infectious meningitis.